Patents Assigned to BIO-Cat, Inc.
  • Bacillus compositions and uses thereof
    Patent number: 10787716
    Abstract: A spore-forming Bacillus species, and more particularly, a Bacillus subtilis strain identified as MB40 is provided. Compositions comprising the MB40 strain, methods of making products comprising the same, and methods of using the same are also provided.
    Type: Grant
    Filed: October 14, 2019
    Date of Patent: September 29, 2020
    Assignee: BIO-CAT, INC.
    Inventors: Christopher S. Penet, Sebhat Gebrechristos, Caroline Helen Best, Deborah S. Winetzky, Robert Daniel Little, Jr., Jessica Spears, Christopher Schuler
  • Bacillus compositions and uses thereof
    Patent number: 10494684
    Abstract: A spore-forming Bacillus species, and more particularly, a Bacillus subtilis strain identified as MB40 is provided. Compositions comprising the MB40 strain, methods of making products comprising the same, and methods of using the same are also provided.
    Type: Grant
    Filed: October 2, 2017
    Date of Patent: December 3, 2019
    Assignee: BIO-CAT, INC.
    Inventors: Christopher S. Penet, Sebhat Gebrechristos, Caroline Helen Best, Deborah S. Winetzky, Robert Daniel Little, Jr., Jessica Spears, Christopher Schuler
  • Methods and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
    Patent number: 9555083
    Abstract: The invention relates to methods and compositions for reducing serum levels of triacylglycerides in human subjects. In particular, the invention relates to the oral administration of an effective amount of a fungal lipase formulation, to a human subject having borderline-high or high serum levels of triacylglycerides, for a time period sufficient to reduce serum triacylglyceride levels.
    Type: Grant
    Filed: September 18, 2012
    Date of Patent: January 31, 2017
    Assignee: BIO-CAT, INC.
    Inventors: Christopher Schuler, Edward Schuler, Christopher S. Penet, Kelly Gregory, K. Gregory Moore
  • METHODS AND COMPOSITIONS TO REDUCE SERUM LEVELS OF TRIACYLGLYCERIDES IN HUMAN BEINGS USING A FUNGAL LIPASE
    Publication number: 20140294802
    Abstract: The invention relates to methods and compositions for reducing serum levels of triacylglycerides in human subjects. In particular, the invention relates to the oral administration of an effective amount of a fungal lipase formulation, to a human subject having borderline-high or high serum levels of triacylglycerides, for a time period sufficient to reduce serum triacylglyceride levels.
    Type: Application
    Filed: September 18, 2012
    Publication date: October 2, 2014
    Applicant: BIO-CAT, INC.
    Inventors: Christopher Schuler, Edward Schuler, Christopher S. Penet, Kelly Gregory, Gregory Moore
  • Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase
    Patent number: 8268305
    Abstract: The invention relates to methods and compositions for reducing serum levels of triacylglycerides in human subjects. In particular, the invention relates to the oral administration of an effective amount of a fungal lipase formulation, to a human subject having borderline-high or high serum levels of triacylglycerides, for a time period sufficient to reduce serum triacylglyceride levels.
    Type: Grant
    Filed: September 23, 2011
    Date of Patent: September 18, 2012
    Assignee: Bio-Cat, Inc.
    Inventors: Christopher Schuler, Edward Schuler, Christopher S. Penet, Gregory Moore, Kelly Gregory
  • Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency
    Patent number: 8071089
    Abstract: The invention provides compositions and methods for treating pancreatic enzyme insufficiency, such as the pancreatic enzyme insufficiency associated with cystic fibrosis. The invention also provides compositions comprising lipase from Candida cylindracea, alone or in combination with amylase or amyloglucosidase, protease and/or lactase. Furthermore, the invention discloses methods for treating pancreatic enzyme insufficiency comprising administering compositions to patients in need thereof.
    Type: Grant
    Filed: October 31, 2006
    Date of Patent: December 6, 2011
    Assignee: BIO-Cat, Inc.
    Inventors: Christopher Schuler, Edward Schuler